Dispersible tablet formulations containing dolutegravir
DE602021031133T2Active Publication Date: 2025-05-21VIIV HEALTHCARE CO
-1 Cites -1 Cited by
Patent Information
- Application Number
- DE602021031133
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-06-25
- Filing Date
- 2021-06-23
- Publication Date
- 2025-05-21
- Estimated Expiration
- 2041-06-23
Abstract
A dispersible tablet formulation comprising dolutegravir or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable ion. A process for making a dispersible tablet formulation as claimed, comprising mixing dolutegravir or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable ion. A dispersible tablet formulation as claimed, for use in therapy. A dispersible tablet formulation as claimed, for use in the treatment of HIV infection.
Need to check novelty before this filing date? Find Prior Art